We report an analytical reversed-phase liquid-chromatographic procedure for quantifying nicotine and cotinine in urine, taking into account the presence of interfering caffeine frequently encountered in such specimens. These analytes are extracted from the alkalinized urine with chloroform. After evaporation of the chloroform, the residue is dissolved in methanol and injected into a chromatographic C18 column. Extraction recoveries averaged 80% to 97%. Chromatographic conditions were investigated to obviate caffeine interference. The proposed eluent mobile phase is a polar mixture of water, acetonitrile, methanol, and a pH 4 acetoacetate buffer (65/2/29/4 by vol) adjusted to pH 4.30 ± 0.02 with triethylamine. High resolution and linearity were obtained for each analyte up to a concentration of 200 mg/L. The minimum detectable amount of each compound was 20 ng per injection, corresponding to 10 g per liter of urine. Correlation with results of gas-liquid chromatography was excellent (r = 0.99). This simple, rapid procedure allows routinescreeningof tobaccoexposurewith acceptableprecision: within-and between-run coefficients of variation were <2% and <5%, respectively.
Studies of the effects of active and passive smoking on the respiratory system require accurate measurements of biochemical markers of tobacco smoke, generally nicotine and its metabolite cotinine.
Among the many existing analytical techniques that have been described for determining the above analytes are radioimmunoassay (1, 2) , gas chromatography-mass spectrophotometry (3), and enzymoimmunoassay (4) . The first routinely used assays of nicotine and cotinine (5) (6) (7) (8) were based on gas-liquid chromatography (GLC) on capillary or packed columns with a nitrogen-sensitive detector or alkali flame ionization.
In the last decade, isocratic "high-performance" liquid chromatography (HPLC) has been the preferred technique for rapid analysis for nicotine and cotimne in all kinds of biological specimens. A reversed-phase ion-paired liquidchromatographic technique has been reported by Machacek and Jiang (9) and more recently by Hariharan et al. (10) , involving sodium heptane sulfonate in buffer solutions. After a tedious extraction procedure, a peak for caffeine appeared in the chromatogram between cotinine and the phenylimidazole used as internal standard. In the classic reversed-phase HPLC, several polar mobile phases have been proposed at different pH (11) (12) (13) (14) . Although none of these authors reported any interference, Hortsmann (14) , in a simple HPLC method for determining nicotine and cotinine in urine, found that 7% of nonsmokers had high urinary concentrations of cotinine. When an eluent mixture similar to that proposed by Kyerematen et al. (13) was used with various stationary phases at pH ranging from 5.0 to 6.8, we also observed a large proportion of high values for cotinine in the urine of smokers, but also in nonsmokers taking medications or drinks containing caffeine. This polar molecule can thus interfere by co-eluting with cotinine. To overcome this problem, we determined chromatographic conditions that, after a simple analytical extraction procedure, gave good resolution of nicotine and cotinine and avoided interference by caffeine. 
MaterIals and Methods

Instrumentation
Standard Solutions
Stock solutions (10 mg/mL) of nicotine, cotinine, or caffeine in methanol were prepared monthly and stored at 4 #{176}C. On the day of the assay, the stock solutions of nicotine and cotinine were diluted with methanol to give working standard solutions with concentrations of 100, 50, and 25 g/mL. We added 100 g of caffeine per milliliter to each working solution. A calibration curve was derived from the peak areas for each nicotine and cotinine solution. For GLC, lidocaine was added to give a final concentration of 50 p.g/mL. GLC procedure: For this, the instrument settings were as follows: injection-port temperature 250 #{176}C, column temperature programming from 90 #{176}C to 220 #{176}C (nicotine emerges at 110 #{176}C, cotinine at 190 #{176}C, caffeine and lidocaine at 200 #{176}C), carrier gas (nitrogen) flow rate 15 mL/min, air flow rate 60 mL/min, and hydrogen flow rate 5 mL/min.
Urine Collection
A morning preprandial urine specimen was collected from each volunteer, who then completed a brief questionnaire concerning his consumption of nicotine-and (or) caffeine-containing products during the previous 48 h. A few volunteers agreed to abstain from drinking caffeinecontaining beverages for at least 48 h before the experiment, as recommended elsewhere (14) . All specimens were stored at -20 #{176}C until assay.
Sample Preparation
In a 30-mL screw-capped centrifuge tube, 10 mL of urine was added to 5 mL of a 5 moJJL solution of sodium hydroxide, 100 L of a methanolic solution of phenylimidazole (200 pg/mL) as internal standard, and 10 mL of chloroform. The tubes were stoppered and agitated for 1 h in a rotary shaker. After centrifugation (3500 x g, 10 mm) an 8-mL aliquot of the organic phase was transferred to a fresh 12-mL tube to be evaporated at 40#{176}C in a water bath, under a stream of nitrogen. For HPLC assay, the extracts were dissolved in 200 L of methanol, then passed through a 0.45-pm Millex HV4 Millipore filter. Of the extract, 20 was loaded onto the column and the sample components were eluted isocratically with the mobile phase at a flow rate of 1 mL/min.
For GLC assay, the extracts (with lidocaine as internal standard) were dissolved in 500 jL of chloroform and then vortex-mixed for 20 s. We injected 2 zL of this solution onto the gas chromatograph.
The efficiency of extraction was evaluated as follows. We 
Results and DIscussIon
Caffeine Interference
Except for the nonsmokers as controls, all of our patients were smokers or involuntarily exposed to tobacco smoke in their work place or life environment. Many of them were being treated for asthma, bronchitis, or pneumonia. Tobacco-marker screening was set up to find the cause of this bronchial reactivity.
Of these subjects, 90% had a high urinary caffeine concentration, ranging from 0.5 to 20 mg/L. All the coffee drinkers who were nonsmokers had a false but appreciable cotinine concentration in their urine when this metabolite marker was assayed by the classical reversed-phase HPLC with the incorrect chromatographic conditions. Caffeine and cotinine were routinely co-eluted by using the pH 6.8 mobile phase defined by Kyerematen et al. (13) and the C18 stationary phases described in Materials and Methods. In addition, at this pH, the cotinine concentrations in the urine of several nonsmokers (mean = 9.5 ug per milliliter of urine; n = 24) fell within the range usually observed for smokers. Two methods for the separation of caffeine from the two principal eluates in the urinary extracts were considered: first, an acidic extraction of caffeine; second, an optimization of the chromatographic technique.
Caffeine Elimination
Caffeine is a polar molecule, soluble in many aqueous and organic solvents. A first acidic extraction step with chloroform before alkaline extraction removed approximately 90% of the caffeine from the urine samples. However, the remaining 10% represents a large quantity of caffeine (a mean of 3.5 p.g/mL was present in the 70 urine samples studied) and clearly can interfere in the chromatograms. Moreover, multiple extraction steps are time consuming and lead to a loss of nicotine and cotiine because of the low partition coefficient of these compounds in the different extraction phases.
Analytical Chromatographic Optimization
The optimal order of elution of the three analytes is as follows: first, nicotine, with a retention time sufficiently different from the methanol peak to avoid endogenous urinary pigments,then cotinine, and finally caffeine. The chromatographic parameters are then defined so as to obtain a good selectivity factor (a = avoiding the overlap of neighboring peaks. Variables found to influence the resolution were:
(a) the composition of the stationary phase in each column (Figure 1) , where k' = (RT -RT0)/RT0 (RT being the retention time of the analyte, RT0 the retention time of methanol);despitethe peak sharpness and large capacity factor obtained with the Hypersil and Novapak columns, we prefer the Partisil and Spherisorb columns for their greater retention power with late separation of the eluates (averaging 5.0-6.0 mm after injection).
(b) the pH of the mobile phase (Figure 2 ), which influences the selectivity factor and the order of resolution, particularly with regard to nicotine. The polarity of nicotine was found to change with the pH: from pH 4.3 to 6.8, nicotine was retained longer by the stationary phase with increasing pH, while above pH 6.4, nicotine was eluted after cotinine. The retention times of cotinine and caffeine did not change significantly with pH, and they were coeluted except at two critical pH, 4.3 and 6.4. At acidic pH, the resolution is probably based on the ionic forms of these molecules (e.g., nicotinium ion). At pH 6.4 the neutral forms are eluted, the order being determined by their molecular masses. (where a = selectivity factor, k' = capacity factor, N = theoretical column plate count), was greatest at pH 4.3 and 6.4, as shown in Figure 2 .
Given the low concentration of nicotine in urine owing to its short biological half-life, we recommend a working pH of 4.3 or 6.4, at which nicotine is first and sharply eluted and the cotinine peak is distinctly separated from the interfering caffeine, which is eluted last. Separation of the caffeine interference is very important, especially in the cases of passive smokers: the urinary cotiine concentration shown in Figure 1C presented a real value of 0.70 g/mL, when measured at the correct pH 4.30, whereas at pH 6.00 the value found was 4.43 pg/mL (error = +628%).
Analytical Variables
Precision: Data on the precision of the assay are summarized in Table 1 . Reproducibility was evaluated by the withinand between-run precision of three standard concentrations. The good CV (mean 1.89%, within-run) was due in part to the use of a U6K injector. Thus, in routine batchwork, use of an internal standard can be omitted to avoid overcrowding the chromatograms. Correlation with GLC: For nicotine and cotinine the correlation coefficient, r, exceeded 0.99 and the equations for the regression curves were respectively y(GLC) = 1.OOi4x (HPLC) + 0.77 (n = 84) and y(GLC) = 0.9963x (HPLC) + 1.15 (n = 92).
Linearity
The concentrations of nicotine and cotinine in these urine samples ranged from 0.10 pg to 6.75 pg per milliliter.
Using GLC, we had never observed co-elution of caffeine with programming column temperature.
Lidocaine is the best internal standard under the chromatographic conditions described. Nevertheless, this method is cumbersome, time-consuming, and inappropriate for routine analysis.
Overloading: After addition of standards to nonsmokers' urine samples, the chromatograms and retention times were compared. No significant difference was observed. Other interference screening: Of our patients, 16% were being treated for allergy (4%), high blood pressure (2%), nervousness or anxiety (8%), or cardiovascular diseases (2%). Thus we investigated the following drugs as potential interferents. An antiallergic drug, terfenadine; an antiasthmatic, theophylline; a /3-blocker, metoprolol; and the antthypertensive agents enalapril maleate and procaine were eluted well before nicotine and cotinine. Drugs that did not interfere: imipramine, promethazine, tetracaine, lignocaine, and theobromine. Stationary phases such as Hypersil and Spherisorb have a greater retention power for the nicotine, cotinine, and caffeine. Moreover, the first i ultraviolet absorption spectrum of the material corresponding to each peak eluted was plotted from 210 to 360 nm. The second-derivative curve proved the purity of each peak and the accuracy of the technique (Figure 3) . During the past 10 years, "high-performance" liquid chromatography has been widely used for measurement of nicotine and cotinine. The most important aim of our study was to investigate rigorously the chromatographic conditions allowing the use of various kinds of stationary phase available in the laboratory, together with a simple polar mobile phase. As illustrated in the diagram depicted in Figure 2 , pH 4.30 or 6.40 must be carefilly maintained for good resolution of the two analytes that are biochemical tobacco-smoke markers.
Usefulness of the Present HPLC Procedure
